New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice
Shulman KI, Sykora K, Gill SS, Mamdani M, Anderson G, Marras C, Wodchis WP, Lee PE, Rochon P. Am J Geriatr Psychiatry. 2005; 13(4):299-304.
Publications
Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study
Shulman KI, Sykora K, Gill S, Mamdani M, Bronskill S, Wodchis WP, Anderson G, Rochon P. J Clin Psychiatry. 2005; 66(4):424-7.
Skilled nursing facility rehabilitation and discharge to home after stroke
Wodchis WP, Teare GF, Naglie G, Bronskill SE, Gill SS, Hillmer MP, Anderson GM, Rochon PA, Fries BE. Arch Phys Med Rehabil. 2005; 86(3):442-8.
Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study
Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SL, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. BMJ. 2005; 330(7489):445. Epub 2005 Jan 24.
Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort
Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Lang AE; Parkinson Study Group. Neurology. 2005; 64(1):87-93.
Representation of patients with dementia in clinical trials of donepezil
Gill SS, Bronskill SE, Mamdani M, Sykora K, Li P, Shulman KI, Anderson GM, Hillmer MP, Wodchis WP, Rochon PA. Can J Clin Pharmacol. 2004; 11(2):e274-85. Epub 2004 Dec 15.
Potentially inappropriate prescribing in Canada relative to the US
Rochon PA, Lane CJ, Bronskill SE, Sykora K, Anderson GM, Mamdani MM, Gurwitz JH, Dhalla IA. Drugs Aging. 2004; 21(14):939-47.
The inclusion of minority groups in clinical trials: problems of under-representation and under-reporting of data
Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Clark JP, Dergal JM, Gold J. Account Res. 2004; 11(3-4):215-23.
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review
Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. BMJ. 2004; 329(7457):75. Epub 2004 Jun 11.
Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community
Rochon PA, Sykora K , Bronskill SE, Mamdani M, Anderson GM, Gurwitz JH, Gill S, Tu JV, Laupacis A. J Gen Intern Med. 2004; 19(6):676-83.